Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 14/20 | 0.79 |
| ▸ | PARP15 | Q460N3 | 4/20 | 0.79 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.79 |
| ▸ | PARP14 | Q460N5 | 2/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.79 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.79 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.79 |
| ▸ | MMP13 | P45452 | 2/20 | 0.61 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.61 |
| ▸ | PARP2 | Q9UGN5 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | PARP1 | P09874 | 1/20 | 0.61 |
| ▸ | TNKS | O95271 | 1/20 | 0.59 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.59 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24592196 | 1.00 | PARP10 (0.79) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL3137816 | 0.89 | PARP10 (1.00) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL22724718 | 0.89 | PARP10 (0.62) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL24124451 | 0.89 | PARP10 (0.62) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL25142213 | 0.87 | PARP10 (0.66) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| Terephthalamide SCHEMBL17907469 | 0.87 | ALDH1A1 (0.62) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL76475 | 0.87 | ALDH1A1 (0.62) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL17865518 | 0.86 | PARP10 (0.70) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL8406724 | 0.86 | PARP10 (0.84) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL10416433 | 0.84 | ALDH1A1 (0.59) | PARP10PARP15PARP4PARP14ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773768-B1 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2018-08-22 | — | — | EP | claimed |
| US-20040002521-A1 | Cyclopropanecarboxylic acid amide compound and pharmaceutical use thereof | AJINOMOTO CO. INC | 2004-01-01 | — | — | US | claimed |
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220354949-A1 | NOVEL COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-10 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| EP-1910374-A1 | AZACYCLIC COMPOUNDS AS INHIBITORS OF SENSORY NEURONE SPECIFIC SODIUM CHANNELS | Vernalis (R&D) Limited (GB) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007007069-A1 | AZACYCLIC COMPOUNDS AS INHIBITORS OF SENSORY NEURONE SPECIFIC SODIUM CHANNELS | VERNALIS (R & D) LIMITED (GB) | 2007-01-18 | — | — | WO | disclosed |
| US-7098215-B2 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 2006-08-29 | — | — | US | disclosed |
| US-20040157818-A1 | Cxcr4-antagonistic drugs composed of nitrogen-containing compound | KUREHA CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1389460-A1 | CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND | Kureha Chemical Industry Co., Ltd. (JP) | 2004-02-18 | — | — | EP | disclosed |
| US-20040002521-A1 | Cyclopropanecarboxylic acid amide compound and pharmaceutical use thereof | AJINOMOTO CO. INC | 2004-01-01 | — | — | US | disclosed |
| WO-2003083063-A2 | COMMON LIGAND MIMICS: NAPHTOATES | TRIAD THERAPEUTICS, INC. (US) | 2003-10-09 | — | — | WO | disclosed |
| EP-1273571-A1 | NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME | Kureha Chemical Industry Co., Ltd. (JP) | 2003-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | NSUN2, ZC3HAV1L, PNP | PARP10 2972/4885PARP15 3515/4885PARP4 4009/4885 |
| US-20220354949-A1 | NOVEL COMPOUNDS | MUSK, TYR, IKZF3 | PARP10 1501/4885PARP15 2576/4885PARP4 3018/4885 |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | PARP10 1897/4885PARP15 2681/4885PARP4 3046/4885 |
| US-20040002521-A1 | Cyclopropanecarboxylic acid amide compound and pharmaceutical use thereof | NFKBIA, IKBKB, CHUK | PARP10 2792/4885PARP15 1220/4885PARP4 2438/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885 |
| US-20040157818-A1 | Cxcr4-antagonistic drugs composed of nitrogen-containing compound | CXCR4, CXCR1, CXCR2 | PARP10 1107/4885PARP15 2068/4885PARP4 2542/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | PARP10 3512/4885PARP15 4342/4885PARP4 3902/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.